レポートナンバー 0000039692
イギリスの病院用止血分析装置・試薬(2024年)- サプライヤーのシェアと戦略、件数と売上の予測、競合情報、技術と計測機器のレビュー、サプライヤーの機会
VPGMarketResearch
2024 UK Hospital Hemostasis Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers
発刊日
2024/10/02
言語英語
体裁PDF
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
レポート概要
このレポートは、以下の内容を含む、イギリスの病院用止血診断検査市場の包括的な分析を示しています。
- イギリスの凝固検査室の実践に関する主要な問題、および今後 5 年間に市場に大きな影響を与える主要な経済、規制、人口、社会、技術の動向
- イギリスの病院で行われている40の凝固手技の件数と売上予測(典型的な凝固手技の1日の作業負荷を含む)
- 現在の計測技術のレビューと主要な分析装置の機能比較
- 試薬・計測機器の売上予測
- 主要試薬・計測機器メーカーの売上高と市場シェア
- 凝固技術とその潜在的な市場応用のレビュー
- 凝固機器と消耗品の主なビジネスチャンス
- 売上高、市場シェア、製品ポートフォリオ、マーケティング戦術、技術ノウハウ、研究開発中の新製品、協業体制、事業戦略など、現在および新興の主要サプライヤーのプロファイル
- 機器・試薬サプライヤーにとってのビジネスチャンスと戦略的推奨事項
レポート詳細
目次
Table of Contents
Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation: Review of latest analyzers from Bio/Data, Cardiovascular
Diagnostics, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory,
NexusDx, Roche Diagnostics, Siemens Healthineers, Sysmex, and Teco
Diagnostics.
C. Major in Vitro Diagnostic Technologies And Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
Country Analysis
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher
List of Tables
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's
Factor Tests
Executive Summary Table: U.K., Hospital Coagulation Diagnostics
Market By Product Category
U.K., Hospital Laboratories Performing Coagulation Tests
By Bed Size
U.K., Hospital Laboratories Average Daily Test Volume
U.K., Hospital Laboratories Coagulation Test Volume by Assay
U.K., Major Suppliers of Coagulation Reagents
Estimated Sales and Market Shares
U.K., Major Suppliers of Coagulation Analyzers,
Estimated Sales and Market Shares
U.K., Total Coagulation Diagnostics Market By Product Category
U.K., Major Suppliers of Coagulation Diagnostic Products,
Estimated Sales and Market Shares